News

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...
The Ohio Board of Pharmacy recently revoked the licenses of four Ohio medical spas, with concerns over the sourcing and ...
Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But the company ...
A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...